These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 13677485)

  • 1. C-QSAR: a database of 18,000 QSARs and associated biological and physical data.
    Kurup A
    J Comput Aided Mol Des; 2003; 17(2-4):187-96. PubMed ID: 13677485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the QSAR's predictive truthfulness of the novel N-tuple discrete derivative indices on benchmark datasets.
    Martínez-Santiago O; Marrero-Ponce Y; Vivas-Reyes R; Rivera-Borroto OM; Hurtado E; Treto-Suarez MA; Ramos Y; Vergara-Murillo F; Orozco-Ugarriza ME; Martínez-López Y
    SAR QSAR Environ Res; 2017 May; 28(5):367-389. PubMed ID: 28590848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors.
    Matter H
    J Med Chem; 1997 Apr; 40(8):1219-29. PubMed ID: 9111296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds.
    Waller CL
    J Chem Inf Comput Sci; 2004; 44(2):758-65. PubMed ID: 15032558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a quantitative structure-activity relationship for chronic narcosis to fish.
    Claeys L; Iaccino F; Janssen CR; Van Sprang P; Verdonck F
    Environ Toxicol Chem; 2013 Oct; 32(10):2217-25. PubMed ID: 23775559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design.
    Roy K; Mitra I
    Comb Chem High Throughput Screen; 2011 Jul; 14(6):450-74. PubMed ID: 21521150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A general method for exploiting QSAR models in lead optimization.
    Lewis RA
    J Med Chem; 2005 Mar; 48(5):1638-48. PubMed ID: 15743205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.
    González-Díaz H; Romaris F; Duardo-Sanchez A; Pérez-Montoto LG; Prado-Prado F; Patlewicz G; Ubeira FM
    Curr Pharm Des; 2010; 16(24):2737-64. PubMed ID: 20642428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of topological descriptors in QSAR and drug design: history and new trends.
    Gozalbes R; Doucet JP; Derouin F
    Curr Drug Targets Infect Disord; 2002 Mar; 2(1):93-102. PubMed ID: 12462157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds.
    Shen M; Béguin C; Golbraikh A; Stables JP; Kohn H; Tropsha A
    J Med Chem; 2004 Apr; 47(9):2356-64. PubMed ID: 15084134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic QSAR techniques: applications in drug design and toxicology.
    Mekenyan O
    Curr Pharm Des; 2002; 8(17):1605-21. PubMed ID: 12052203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional molecular descriptors and a novel QSAR method.
    Wildman SA; Crippen GM
    J Mol Graph Model; 2002 Dec; 21(3):161-70. PubMed ID: 12463634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Topological, Electronic, Geometrical, Constitutional and Quantum Chemical Based Descriptors in QSAR: mPGES-1 as a Case Study.
    Gupta A; Kumar V; Aparoy P
    Curr Top Med Chem; 2018; 18(13):1075-1090. PubMed ID: 30027847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling robust QSAR.
    Polanski J; Bak A; Gieleciak R; Magdziarz T
    J Chem Inf Model; 2006; 46(6):2310-8. PubMed ID: 17125174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using kernel alignment to select features of molecular descriptors in a QSAR study.
    Wong WW; Burkowski FJ
    IEEE/ACM Trans Comput Biol Bioinform; 2011; 8(5):1373-84. PubMed ID: 21339534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology.
    Perkins R; Fang H; Tong W; Welsh WJ
    Environ Toxicol Chem; 2003 Aug; 22(8):1666-79. PubMed ID: 12924569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AutoWeka: toward an automated data mining software for QSAR and QSPR studies.
    Nantasenamat C; Worachartcheewan A; Jamsak S; Preeyanon L; Shoombuatong W; Simeon S; Mandi P; Isarankura-Na-Ayudhya C; Prachayasittikul V
    Methods Mol Biol; 2015; 1260():119-47. PubMed ID: 25502379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a methodology for an inverse quantitative structure-activity relationship using the signature molecular descriptor.
    Visco DP; Pophale RS; Rintoul MD; Faulon JL
    J Mol Graph Model; 2002 Jun; 20(6):429-38. PubMed ID: 12071277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing Enhanced Blood-Brain Barrier Permeability Models: Integrating External Bio-Assay Data in QSAR Modeling.
    Wang W; Kim MT; Sedykh A; Zhu H
    Pharm Res; 2015 Sep; 32(9):3055-65. PubMed ID: 25862462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.